Graph takes few seconds to load...
Japan Tissue Engineering Co., Ltd. engages in the regenerative medicine business in Japan. The company offers autologous cultured epidermis and cartilage to medical institutions for the purpose of medical treatment.
It also provides tissue-engineered medical products, which are used in autologous transplant cases, where living cells are taken from the actual patient himself, cultured, and then transplanted back to the same patient.
In addition, the company researches and develops human 3-dimensional cultured tissue models for use in the development of cosmetics and drugs for external use, as well as in research that employs skin and cornea tissues.
Further, it offers regenerative medical products contract development and manufacturing, and contract research services. Japan Tissue Engineering Co., Ltd. was founded in 1999 and is headquartered in Gamagori, As of March 2, 2021, Japan Tissue Engineering Co., Ltd. operates as a subsidiary of Teijin Limited.
| Annual Data | Millions of US $ except per share data | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 | 2016-03-31 | 2015-03-31 |
|---|---|---|---|---|---|---|
| Cash on hand | - | - | - | - | - | - |
| Receivables | - | $641.43 | $543.04 | $788.09 | $454 | $403 |
| Inventory | - | $146.27 | $135.19 | $105.15 | $123 | $138 |
| Pre-Paid Expenses | - | - | - | - | - | - |
| Other Current Assets | - | $195.30 | $156.01 | $21.33 | $58 | $149 |
| Total Current Assets | - | $7,024.20 | $7,139.67 | $5,070.38 | $4,501 | $6,672 |
| Property, Plant, And Equipment | $1,621 | $1,651 | $1,656 | $1,725 | $1,821 | $1,697 |
| Long-Term Investments | - | $4 | $204 | $1,706 | $1,909 | $409 |
| Goodwill And Intangible Assets | - | - | - | - | - | - |
| Other Long-Term Assets | $1 | $54 | $1 | $8 | $17 | $27 |
| Total Long-Term Assets | - | $1,727.77 | $1,883.40 | $3,475.98 | - | - |
| Total Assets | - | $8,751.97 | $9,023.07 | $8,546.37 | $8,296 | $8,853 |
| Total Current Liabilities | - | $795.90 | $733.85 | $498.43 | $490 | $346 |
| Long Term Debt | - | - | - | - | - | - |
| Other Non-Current Liabilities | $36 | $35 | $37 | $36 | $74 | $92 |
| Total Long Term Liabilities | - | $37.95 | $37.79 | $42.80 | - | - |
| Total Liabilities | - | $833.85 | $771.64 | $541.23 | $578 | $456 |
| Common Stock Net | $4,958 | $4,958 | $4,958 | $4,949 | $11,518 | $11,517 |
| Retained Earnings (Accumulated Deficit) | $-116 | $170.88 | $504.13 | $276.24 | $-13,149 | $-12,467 |
| Comprehensive Income | - | - | - | - | - | - |
| Other Share Holders Equity | $1 | $2 | $1 | $1 | $1 | - |
| Share Holder Equity | - | $7,918.12 | $8,251.43 | $8,005.14 | $7,718 | $8,397 |
| Total Liabilities And Share Holders Equity | - | - | - | - | - | - |
